Researcher

Shuo Liang

Aerospace Center Hospital

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · JOURNAL ARTICLE

UQCRC2 lactylation-mediated mitophagy orchestrates colorectal cancer cell metabolism to establish a drug-tolerant state during chemotherapy

Molecular Cancer

Mechanistic study in cell and animal models identifying a pathway linking lactylation to drug tolerance, with clinical associations but no prospective clinical trial or intervention outcome data.

Hypothesis-GeneratingShuo Liang Cancer Cells and Metastasis Xiang Zhao

Reported

Clinical outcome correlationLow tumor UQCRC2-K430la associated with poo…

CTC biomarker associationIncreased SIRT1 or decreased UQCRC2-K430la…

SEP 7, 2026 · JOURNAL ARTICLE

Therapeutic drug monitoring in leukemia: global research trends and implications for clinical pharmacy practice—a bibliometric analysis

International Journal of Clinical Pharmacy

A bibliometric analysis of publication trends and research hotspots in therapeutic drug monitoring for leukemia; describes the research landscape rather than testing a clinical hypothesis or reporting primary outcome data.

PreliminaryLichaoyue Sun Chronic Myeloid Leukemia Treatments Shuo Liang

Reported

Total publications retrieved859

Highest annual output period58 papers between 2024–2025

Study periodJanuary 1, 2001 to December 31, 2025